Opus Investment Management’s Gilead Sciences GILD Stock Holding History

Opus Investment Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15,300	Closed	-$1.18M	–	55
2023 Q2	$1.18M	Hold	15,300	–	–	0.42%	63
2023 Q1	$1.27M	Hold	15,300	–	–	0.46%	61
2022 Q4	$1.31M	Sell	15,300 -52,500	-77%	-$4.16M	0.47%	61
2022 Q3	$4.18M	Hold	67,800	–	–	0.97%	37
2022 Q2	$4.19M	Hold	67,800	–	–	0.91%	40
2022 Q1	$4.03M	Buy	67,800 +7,500	+12%	+$479K	0.62%	57
2021 Q4	$4.38M	Hold	60,300	–	–	0.63%	57
2021 Q3	$4.21M	Hold	60,300	–	–	0.64%	50
2021 Q2	$4.15M	Buy	+60,300	New	+$4.03M	0.63%	50

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Opus Investment Management's GILD Position: Q3 2023 in Review

Opus Investment Management sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 15,300 shares — an estimated $1.18M sold.

Opus Investment Management first reported a position in GILD in Q2 2021 and held it in 9 quarters. The position peaked at $4.38M in Q4 2021. 1,682 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

Opus Investment Management reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
Opus Investment Management sold 15,300 Gilead Sciences shares in Q3 2023, an estimated $1.18M.
Opus Investment Management first reported a position in Gilead Sciences in Q2 2021 and held it in 9 quarters.
Opus Investment Management's Gilead Sciences position peaked at $4.38M in Q4 2021.
1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Opus Investment Management's 13F filing for Q3 2023, filed 8 Nov 2023.